Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings.
Chiu PK, Ng CF, Semjonow A, Zhu Y, Vincendeau S, Houlgatte A, Lazzeri M, Guazzoni G, Stephan C, Haese A, Bruijne I, Teoh JY, Leung CH, Casale P, Chiang CH, Tan LG, Chiong E, Huang CY, Wu HC, Nieboer D, Ye DW, Bangma CH, Roobol MJ. Chiu PK, et al. Among authors: nieboer d. Eur Urol. 2019 Apr;75(4):558-561. doi: 10.1016/j.eururo.2018.10.047. Epub 2018 Nov 2. Eur Urol. 2019. PMID: 30396635
Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.
Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MG. Schoots IG, et al. Among authors: nieboer d. Eur Urol. 2015 Sep;68(3):438-50. doi: 10.1016/j.eururo.2014.11.037. Epub 2014 Dec 3. Eur Urol. 2015. PMID: 25480312 Review.
Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer.
Venderbos LD, Roobol MJ, Bangma CH, van den Bergh RC, Bokhorst LP, Nieboer D, Godtman R, Hugosson J, van der Kwast T, Steyerberg EW. Venderbos LD, et al. Among authors: nieboer d. World J Urol. 2016 Feb;34(2):253-60. doi: 10.1007/s00345-015-1628-y. Epub 2015 Jul 10. World J Urol. 2016. PMID: 26160006 Free PMC article. Clinical Trial.
Prostate cancer risk prediction using the novel versions of the European Randomised Study for Screening of Prostate Cancer (ERSPC) and Prostate Cancer Prevention Trial (PCPT) risk calculators: independent validation and comparison in a contemporary European cohort.
Poyet C, Nieboer D, Bhindi B, Kulkarni GS, Wiederkehr C, Wettstein MS, Largo R, Wild P, Sulser T, Hermanns T. Poyet C, et al. Among authors: nieboer d. BJU Int. 2016 Mar;117(3):401-8. doi: 10.1111/bju.13314. Epub 2015 Oct 5. BJU Int. 2016. PMID: 26332503 Free article. Clinical Trial.
Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies.
van Leeuwen PJ, Siriwardana A, Roobol M, Ting F, Nieboer D, Thompson J, Delprado W, Haynes AM, Brenner P, Stricker P. van Leeuwen PJ, et al. Among authors: nieboer d. Prostate Cancer. 2016;2016:7105678. doi: 10.1155/2016/7105678. Epub 2016 Apr 11. Prostate Cancer. 2016. PMID: 27148459 Free PMC article.
268 results